DCOY
Decoy Therapeutics Inc.
NASDAQ: DCOY · HEALTHCARE · BIOTECHNOLOGY
$5.54
+1.19% today
Updated 2026-04-29
Market cap
$2.89M
P/E ratio
—
P/S ratio
15.86x
EPS (TTM)
$-129.10
Dividend yield
—
52W range
$5 – $239
Volume
0.1M
Decoy Therapeutics Inc. (DCOY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.93M | $-20.75M | $-32.05M | $-27.72M | $-23.60M | $-11.58M | $-10.31M | $-10.20M | $-17.60M | $-12.85M | $-4.53M | $-4.83M |
| Capital expenditures | $76137.00 | $265617.00 | $559378.00 | $113498.00 | $0.00 | $4.00 | $2600.00 | $3.00 | $1.50M | $3.00 | $3.00 | $577000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $6.60M | $6.57M | $4.22M | $1.94M | $751618.00 | $319391.00 | $559044.00 | $796803.00 | $524838.00 | $273730.00 | $219058.00 |
| Free cash flow | $-7.01M | $-21.01M | $-32.61M | $-27.84M | $-23.60M | $-11.58M | $-10.31M | $-10.20M | $-19.10M | $-12.85M | $-4.53M | $-5.40M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $133594.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |